Analyzing FOXO3A gene as a marker in adults with hypertension
Abstract
Hypertension remains a global health problem. It caused high morbidity and death. It occurs in people in low- and middle-income countries which aged 30 to 80 years old. Symptoms are often asymptomatic; it became unaware until reached an advanced stage. Vascular aging is suspected to be one of the causes of high blood pressure. Modification layers of blood vessels such as thick, stiff, and inelastic, are caused by oxidative stress. This development is influenced by the FOXO3A gene. FOXO3A plays a role in slowing aging which is a transcription factor that plays a role in signal modulation, cell death, oxidation-reduction reactions, cell metabolism and DNA damage. Previous research on FOXO3A gene expression in people over 70 years of age found significantly lower levels compared to those aged 50-60 years. Because of the limited knowledge regarding FOXO3A gene expression in hypertension, this study aims to analyzed FOXO3A gene expression in the elderly. Sixty subjects were divided into hypertension and normotension based on JNC 8 criteria. Quantitative Real Time PCR was used to calculate FOXO3A expression. The Livak formula was used to measure elative expression. FOXO3A relative expression was 7.95 fold lower in hypertension than normotension. FOXO3A expression was reduced in hypertension. Further research at the protein level is needed to confirm these findings.
Keywords: hypertension, expression, mRNA, FOXO3A
Keywords:
hypertension , expression, mRNADOI
https://doi.org/10.22270/jddt.v16i4.7697References
1. Harrison DG, Coffman TM, Wilcox CS. Pathophysiology of Hypertension: The Mosaic Theory and Beyond. Circ Res. 2021;128(7):847–63. Available from: https://pubmed.ncbi.nlm.nih.gov/33793328/
2. Meiyanti M, Yohana , Margo E, Chudri J, Pusparini ,, Faradilla MA. Factors Associated with Plasma Malondialdehyde Levels in People over 40 Years. Journal of Drug Delivery and Therapeutics. 2023 Jul 15;13(7):52–6. Available from: https://jddtonline.info/index.php/jddt/article/view/6142
3. Margo E, Meiyanti , Chondro F, Kartadinata E, Yohana ,. Relationship Blood Pressure and Exercise with Vitamin D Levels in Employees. Journal of Drug Delivery & Therapeutics [Internet]. 2022;12(5-S):27. Available from: https://openurl.ebsco.com/contentitem/doi:10.22270%2Fjddt.v12i5-s.5709?sid=ebsco:plink:crawler&id=ebsco:doi:10.22270%2Fjddt.v12i5-s.5709
4. Foote K, Rienks M, Schmidt L, Theofilatos K, Yasmin, Ozols M, et al. Oxidative DNA damage promotes vascular ageing associated with changes in extracellular matrix-regulating proteins. Cardiovasc Res [Internet]. 2025;121(4):614–28. Available from: https://pubmed.ncbi.nlm.nih.gov/38717632/
5. Yan R, Zhang X, Xu W, Li J, Sun Y, Cui S, et al. ROS-Induced Endothelial Dysfunction in the Pathogenesis of Atherosclerosis. Aging Dis. 2024;16(1):250. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11745424/
6. Hardiany NS, Nurfiyana W, Iswanti FC. Polymorphism of the Forkhead box-O3 (FOXO3) Longevity Gene rs2802292 and senescence-associated secretory phenotype (SASP) in Indonesian Elderly Population. Nutr Healthy Aging. 2024;9(1):47–54. Available from: /doi/pdf/10.3233/NHA-231516?download=true
7. Nurfiyana W, Iswanti FC, Hardiany NS. T Allele of FOXO3 rs2802292 Increases CCL2 Concentration and Slightly Decreases TGF-β Concentration in Indonesian Elderly. Molecular and Cellular Biomedical Sciences. 2024 Nov 1;8(3):167.
8. Yohana Y, Faradilla MA, Tungka EX, Kurniasari K. Gene expression of sirtuin-1 in adult with hypertension. JPBIO (Jurnal Pendidikan Biologi). 2025 Apr 30;10(1):50–8.
9. Chen R, Morris BJ, Donlon TA, Nakagawa K, Allsopp RC, Willcox BJ, et al. FOXO3 Longevity Genotype Mitigates Risk Posed by Hypertension on Incident Coronary Artery Disease in Middle-Aged Men: Kuakini Honolulu Heart Program. J Gerontol A Biol Sci Med Sci. 2024;79(12):glae254. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11642614/
10. Nakagawa K, Chen R, Greenberg SM, Ross GW, Willcox BJ, Donlon TA, et al. Forkhead box O3 longevity genotype may attenuate the impact of hypertension on risk of intracerebral haemorrhage. J Hypertens [Internet]. 2022;40(11):2230. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9553272/
11. Yohana Y, Faradilla MA, Meiyanti M, Hartanti MD, Margo E, Anastasya KS. mRNA Relative Expression Catalase in Hypertension. Bioscientist : Jurnal Ilmiah Biologi. 2024 Sep 28;12(2):1821.
12. Hardiany NS, Karman AP, Safa A, Calista P, Anindyanari BG, Rahardjo DE, et al. The Effect of Fasting on Oxidative Stress in the Vital Organs of New Zealand White Rabbit [Internet]. Vol. 11, Reports of Biochemistry & Molecular Biology. 2022. Available from: www.RBMB.net
13. Hardiany NS, Paramita R, Sucitra. The mRNA expression of Forkhead box O3a (FOXO3a) as a longevity-associated gene in leucocytes of elderly women [Internet]. Vol. 2. Jurnal Pakistan Medical Association; 2021. p. 74–7. Available from: https://pubmed.ncbi.nlm.nih.gov/33785946/
14. Mizani S, Keshavarz A, Vazifeh Shiran N, Bashash D, Allahbakhshian Farsani M. Expression Changes of SIRT1 and FOXO3a Significantly Correlate with Oxidative Stress Resistance Genes in AML Patients. Indian Journal of Hematology & Blood Transfusion. 2022;39(3):392. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10247606/
15. Qin H, Zhang H, Zhang X, Zhang S, Zhu S, Wang H. Resveratrol attenuates radiation enteritis through the SIRT1/FOXO3a and PI3K/AKT signaling pathways. Biochem Biophys Res Commun [Internet]. 2021;554:199–205. Available from: https://pubmed.ncbi.nlm.nih.gov/33812084/
16. Lin D, Luo H, Dong B, He Z, Ma L, Wang Z, et al. FOXO3a Induces Myocardial Fibrosis by Upregulating Mitophagy. Front Biosci (Landmark Ed) [Internet]. 2024;29(2). Available from: https://pubmed.ncbi.nlm.nih.gov/38420796/
17. Yu W, Gao B, Li N, Wang J, Qiu C, Zhang G, et al. Sirt3 deficiency exacerbates diabetic cardiac dysfunction: Role of Foxo3A-Parkin-mediated mitophagy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2017;1863(8):1973–83. Available from: https://doi.org/10.2337/db12-1625
18. Sun T, Han Y, Li JL, Jiao XY, Zuo L, Wang J, et al. FOXO3a-dependent PARKIN negatively regulates cardiac hypertrophy by restoring mitophagy. Cell & Bioscience 2022 12:1 [Internet]. 2022;12(1):204-. Available from: https://link.springer.com/article/10.1186/s13578-022-00935-y
19. Torigoe TH, Willcox DC, Shimabukuro M, Higa M, Gerschenson M, Andrukhiv A, et al. Novel protective effect of the FOXO3 longevity genotype on mechanisms of cellular aging in Okinawans. npj Aging 2024 10:1. 2024;10(1):18-. Available from: https://www.nature.com/articles/s41514-024-00142-8
Published
Abstract Display: 26 
PDF Downloads: 28 PDF Downloads: 2 How to Cite
Issue
Section
Copyright (c) 2026 Yohana Yohana , Meiyanti Meiyanti , Deasyka Yastani , Zakiaturahhmi Zakiaturahhmi , Suweino Tjhia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.